Marea Therapeutics
Cardiometabolic Therapeutics

Marea Therapeutics news and milestones

Marea Therapeutics: 18 headlines on record, 5 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 17, 2026 · Back to the company report
18Headlines
5In 90 days
2Milestones

Headlines

Oct 52026
Press release
Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as on…
Sep 182026
Blog
The post Marea Corporate Presentation appeared first on Marea Therapeutics.
Sep 172026
Press release
Combined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases Marea has multiple late-stage clinical product candidates: MAR001/00…
Jun 252026
Award
The post San Francisco Business Times Best Places to Work 2026 appeared first on Marea Therapeutics.
May 262026
Press release
South San Francisco, Calif., May 26, 2026 - Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-…
Jan 132026
Press release
Company provides 2026 corporate outlook highlighting multiple clinical catalysts across first-in-class cardioendocrine pipeline MAR002 Phase 1 Data: Robust, durable IGF-1 suppres…
Jan 52026
Press release
South San Francisco, Calif., January 5, 2026 - Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-…
Dec 8, 20252025
Blog
The post 2025 Global CVCT Forum: A Novel ANGPTL4 Inhibitory Antibody (MAR001) Safey Lowers Plasma Triglycerides and Remnant Cholesterol in Humans appeared first on Marea Therapeu…
Aug 25, 20242024
Jun 19, 20242024
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Marea Therapeutics, News. Alion, Nov 17, 2026. https://alion.io/company/mareatx/news

.json · .md · CC BY-SA 4.0